Storage lesion: Role of red blood cell breakdown

Transfusion

Volumn 51, Issue 4, 2011, Pages 844-851

  Kim Shapiro, Daniel B ^a,b   Lee, Janet ^a,b   Gladwin, Mark T ^a,b  

^a WAKE FOREST UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; NITRIC OXIDE SYNTHASE;

BLOOD FLOW; BLOOD STORAGE; CELL FREE SYSTEM; CONFERENCE PAPER; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HEMOLYSIS; HUMAN; INFLAMMATION;

BLOOD PRESERVATION; BLOOD TRANSFUSION; ERYTHROCYTES; HEMOGLOBINS; HEMOLYSIS; HUMANS; NITRIC OXIDE;

EID: 79954600715     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03100.x     Document Type: Conference Paper

References (97)

1. Dern RJ, Brewer GJ, Wiorkowski JJ,. Studies on the preservation of human blood. II. The relationship of erythrocyte adenosine triphosphate levels and other in vitro measures to red cell storageability. J Lab Clin Med 1967; 69: 968-78.
2. Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR,. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124: 684-94.
3. Beutler E, Kuhl W,. Volume control of erythrocytes during storagea′the role of mannitol. Transfusion 1988; 28: 353-7.
4. Latham JT, Bove JR, Weirich FL,. Chemical and hematologic changes in stored Cpda-1 blood. Transfusion 1982; 22: 158-9. (Pubitemid 12100250)
5. Greenwalt TJ, Sostok CZ, Dumaswala UJ,. Studies in red-blood-cell preservation. 2. Comparison of vesicle formation, morphology, and membrane-lipids during storage in as-1 and Cpda-1. Vox Sang 1990; 58: 90-3. (Pubitemid 20121366)
6. 2 equilibrium of carboxypeptidase digests of human hemoglobin. Arch Biochem Biophys 1968; 123: 163-5.
7. Beutler E, Meul A, Wood LA,. Depletion and regeneration of 2,3-diphosphoglyceric acid in stored red blood cells. Transfusion 1969; 9: 109-15.
8. Bunn HF, May MH, Kocholaty WF, Shields CE,. Hemoglobin function in stored blood. J Clin Invest 1969; 48: 311-21.
9. Klein HG, Spahn DR, Carson JL,. Transfusion medicine 1a′red blood cell transfusion in clinical practice. Lancet 2007; 370: 415-26. (Pubitemid 47176657)
10. Berezina TL, Zaets SB, Morgan C, Spillert CR, Kamiyama M, Spolarics Z, Deitch EA, Machiedo GW,. Influence of storage on red blood cell rheological properties. J Surg Res 2002; 102: 6-12.
11. Haradin AR, Weed RI, Reed CF,. Changes in physical properties of stored erythrocytes. Transfusion 1969; 9: 229-35.
12. d'Almeida MS, Jagger J, Duggan M, White M, Ellis C, Chin-Yee IH,. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion. Transfus Med 2000; 10: 291-303. (Pubitemid 32062545)
13. Izzo P, Manicone A, Spagnuolo A, Lauta VM, Di Pasquale A, Di Monte D,. Erythrocytes stored in CPD SAG-mannitol: evaluation of their deformability. Clin Hemorheol Microcirc 1999; 21: 335-9. (Pubitemid 30130915)
14. Card RT, Mohandas N, Perkins HA, Shohet SB,. Deformability of stored red blood cellsa′relationship to degree of packing. Transfusion 1982; 22: 96-101. (Pubitemid 12100236)
15. Card RT, Mohandas N, Mollison PL,. Relationship of post-transfusion viability to deformability of stored red-cells. Br J Haematol 1983; 53: 237-40. (Pubitemid 13171496)
16. Aubuchon JP, Estep TN, Davey RJ,. The effect of the plasticizer Di-2-ethylhexyl phthalate on the survival of stored RBCs. Blood 1988; 71: 448-52. (Pubitemid 18089535)
17. Salzer U, Zhu R, Luten M, Isobe H, Pastushenko V, Perkmann T, Hinterdorfer P, Bosman GJ,. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008; 48: 451-62. (Pubitemid 351294572)
18. Greenwalt TJ, McGuinness CG, Dumaswala UJ,. Studies in red-blood-cell preservation. 4. Plasma vesicle hemoglobin exceeds free hemoglobin. Vox Sang 1991; 61: 14-7.
19. Lutz HU, Liu SC, Palek J,. Release of spectrin-free vesicles from human erythrocytes during ATP depletion. 1. Characterization of spectrin-free vesicles. J Cell Biol 1977; 73: 548-60. (Pubitemid 8115192)
20. Tinmouth A, Fergusson D, Yee IC, Hebert PC,. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46: 2014-27. (Pubitemid 44631611)
21. Zallen G, Offner PJ, Moore EE, Blackwell J, Ciesla DJ, Gabriel J, Denny C, Silliman CC,. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999; 178: 570-2. (Pubitemid 30058313)
22. Moore FA, Moore EE, Sauaia A,. Blood transfusiona′an independent risk factor for postinjury multiple organ failure. Arch Surg 1997; 132: 620-5. (Pubitemid 27255607)
23. Marik PE, Sibbald WJ,. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024-9. (Pubitemid 23164346)
24. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC,. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002; 137: 711-6.
25. Purdy FR, Tweeddale MG, Merrick PM,. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997; 44: 1256-61. (Pubitemid 28080688)
26. Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL, Marín-Niebla A, Herruzo-Avilés A, Camacho-Laraña P, Loscertales J,. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003; 98: 815-22. (Pubitemid 36373213)
27. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH,. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39. (Pubitemid 351439224)
28. Walsh TS, McArdle F, McLellan SA, Maciver C, Maginnis M, Prescott RJ, McClelland DB,. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004; 32: 364-71. (Pubitemid 38234112)
29. Klein HG,. Getting older is not necessarily getting better. Anesthesiology 2003; 98: 807-8. (Pubitemid 36373211)
30. Adamson JW,. New blood, old blood, or no blood? N Engl J Med 2008; 358: 1295-6. (Pubitemid 351439233)
31. Vamvakas EC, Carven JH,. Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion 2000; 40: 101-9. (Pubitemid 30053552)
32. de Watering LV, Lorinser J, Versteegh M, Westendord R, Brand A,. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006; 46: 1712-8. (Pubitemid 44435723)
33. Edgren G, Kamper-Jorgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O,. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion 2010; 50: 1185-95.
34. Triulzi DJ, Yazer MH,. Clinical studies of the effect of blood storage on patient outcomes. Transfus Apher Sci 2010; 43: 95-106.
35. Lee JS, Gladwin MT,. Bad blood: the risks of red cell storage. Nat Med 2010; 16: 381-2.
36. Furchgott RF, Zawadzki JV,. The obligatory role of endothelial-cells in the relaxation of arterial smooth-muscle by acetylcholine. Nature 1980; 288: 373-6. (Pubitemid 11169009)
37. Ignarro LJ, Byrns RE, Buga GM, Wood KS,. Endothelium-derived relaxing factor from pulmonary-artery and vein possesses pharmacological and chemical properties identical to those of nitric-oxide radical. Circ Res 1987; 61: 866-79. (Pubitemid 18004583)
38. Katsuki S, Arnold W, Mittal C, Murad F,. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric-oxide in various tissue preparations and comparison to effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977; 3: 23-35. (Pubitemid 8078230)
39. Palmer RM, Ferrige AG, Moncada S,. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6. (Pubitemid 17085822)
40. Schmidt PM, Schramm M, Schroder H, Wunder F, Stasch JP,. Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase. J Biol Chem 2004; 279: 3025-32. (Pubitemid 38114295)
41. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, Darley-Usmar VM,. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999; 1411: 385-400. (Pubitemid 29221963)
42. Ignarro LJ,. Nitric oxide biology and pathobiology. San Diego (CA): Academic Press; 2000.
43. Kleinbongard P, Schulz R, Rassaf T, Lauer T, Dejam A, Jax T, Kumara I, Gharini P, Kabanova S, Ozüyaman B, Schnürch HG, Gödecke A, Weber AA, Robenek M, Robenek H, Bloch W, Rösen P, Kelm M,. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2005; 107: 2943-51.
44. Doyle MP, Hoekstra JW,. Oxidation of nitrogen-oxides by bound dioxygen in hemoproteins. J Inorg Biochem 1981; 14: 351-8. (Pubitemid 11006175)
45. Eich RF, Li TS, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, Johnson KA, Smith RD, Phillips GN Jr, Olson JS,. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996; 35: 6976-83. (Pubitemid 26182085)
46. Herold S, Exner M, Nauser T,. Kinetic and mechanistic studies of the NO*-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry 2001; 40: 3385-95. (Pubitemid 32221642)
47. Lancaster JR,. Simulation of the diffusion and reaction of endogenously produced nitric-oxide. Proc Natl Acad Sci U S A 1994; 91: 8137-41.
48. Carlsen E, Comroe JH,. The rate of uptake of carbon monoxide and of nitric oxide by normal and human erythrocytes and experimentally produced spherocytes. J Gen Physiol 1958; 42: 83-107.
49. Coin JT, Olson JS,. Rate of oxygen-uptake by human red blood-cells. J Biol Chem 1979; 254: 1178-90. (Pubitemid 9148352)
50. Butler AR, Megson IL, Wright PG,. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta 1998; 1425: 168-76. (Pubitemid 28479723)
51. Vaughn MW, Kuo L, Liao JC,. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am J Physiol Heart Circ Physiol 1998; 43: H2163-76.
52. Liao JC, Hein TW, Vaughn MW, Huang KT, Kuo L,. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A 1999; 96: 8757-61. (Pubitemid 29354864)
53. Vaughn MW, Huang KT, Kuo L, Liao JC,. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 2000; 275: 2342-8. (Pubitemid 30081991)
54. Vaughn MW, Huang KT, Kuo L, Liao JC,. Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide 2001; 5: 18-31. (Pubitemid 34146168)
55. Liu XP, Samouilov A, Lancaster JR, Zweier JL,. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J Biol Chem 2002; 277: 26194-9. (Pubitemid 34967106)
56. Huang KT, Han TH, Hyduke DR, Vaughn MW, Van Herle H, Hein TW, Zhang C, Kuo L, Liao JC,. Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A 2001; 98: 11771-6. (Pubitemid 32928804)
57. Liu XP, Miller MJ, Joshi MS, Sadowska-Krowicka H, Clark DA, Lancaster JR Jr,. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 1998; 273: 18709-13. (Pubitemid 28366253)
58. Azarov I, Huang KT, Basu S, Gladwin MT, Hogg N, Kim-Shapiro DB,. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem 2005; 280: 39024-32. (Pubitemid 41713852)
59. Vaughn MW, Kuo L, Liao JC,. Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol Heart Circ Physiol 1998; 43: H1705-14.
60. Kim-Shapiro DB, Schechter AN, Gladwin MT,. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 2006; 26: 697-705. (Pubitemid 43732141)
61. Kevil CG, Patel RP,. S-Nitrosothiol biology and therapeutic potential in metabolic disease. Curr Opin Investig Drugs 2010; 11: 1127-34.
62. Knott AB, Bossy-Wetzel E,. Impact of nitric oxide on metabolism in health and age-related disease. Diabetes Obes Metab 2010; 12: 126-33.
63. Shimokawa H, Tsutsui M,. Nitric oxide synthases in the pathogenesis of cardiovascular disease. Pflugers Arch 2010; 459: 959-67.
64. Virdis A, Ghiadoni L, Giannarelli C, Taddei S,. Endothelial dysfunction and vascular disease in later life. Maturitas 2010; 67: 20-4.
65. Ferrari CK, Franca EL, Honorio-Franca AC,. Nitric oxide, health and disease. J Appl Biomed 2009; 7: 163-73.
66. Rother RP, Bell L, Hillmen P, Gladwin MT,. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-62. (Pubitemid 40471796)
67. Hess JR, Macdonald VW, Brinkley WW,. Systemic and pulmonary-hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74: 1769-78. (Pubitemid 23133473)
68. Lee R, Neya K, Svizzero TA, Vlahakes GJ,. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995; 79: 236-42.
69. Vogel WM, Dennis RC, Cassidy G, Apstein CS, Valeri CR,. Coronary constrictor effect of stroma-free hemoglobin-solutions. Am J Physiol 1986; 251: H413-20.
70. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL,. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109: 1241-8.
71. Reiter CD, Wang XD, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT,. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8: 1383-9. (Pubitemid 36019423)
72. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, Solomon SB,. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005; 115: 3409-17. (Pubitemid 43121829)
73. Jeffers A, Gladwin MT, Kim-Shapiro DB,. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic Biol Med 2006; 41: 1557-65. (Pubitemid 44550083)
74. Gladwin MT,. Unraveling the hemolytic subphenotype of sickle cell disease. Blood 2005; 106: 2925-6. (Pubitemid 41565872)
75. Kato GJ, McGowan VR, Machado RF, Little JA, Taylor J 6th, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM Jr, Gladwin MT,. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood 2006; 107: 2279-85. (Pubitemid 43345545)
76. Nolan VG, Wyszynski DF, Farrer LA, Steinberg MH,. Hemolysis-associated priapism in sickle cell disease. Blood 2005; 106: 3264-7. (Pubitemid 41565928)
77. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP,. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-95. (Pubitemid 38252536)
78. Morris CR, Kato GJ, Poijakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT,. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294: 81-90. (Pubitemid 41002842)
79. Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP,. Pulmonary hypertension and NO in sickle cell. Blood 2010; 116: 852-4.
80. Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rosse WF, Ware RE,. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 2010; 116: 687-92.
81. Gladwin MT, Kim-Shapiro DB,. Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis. Curr Opin Hematol 2009; 16: 515-23.
82. Han TH, Liao JC,. Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim Biophys Acta 2005; 1723: 135-42. (Pubitemid 40744681)
83. Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, Francis KP, Della-Latta P, Whittier S, Sheth S, Hendrickson JE, Zimring JC, Brittenham GM, Spitalnik SL,. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010; 115: 4284-92.
84. Mangalmurti NS, Xiong Z, Hulver M, Ranganathan M, Liu XH, Oriss T, Fitzpatrick M, Rubin M, Triulzi D, Choi A, Lee JS,. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. Blood 2009; 113: 1158-66.
85. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G,. Pro-oxidant and cytotoxic effects of circulating heme. Blood 2002; 100: 879-87. (Pubitemid 34832613)
86. Xiong Z, Cavaretta J, Qu L, Stolz DB, Triulzi D, Lee JS,. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011; 51: 610-21.
87. Westerman M, Pizzey A, Hirschman J, Cerino M, Weil-Weiner Y, Ramotar P, Eze A, Lawrie A, Purdy G, Mackie I, Porter J,. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 2008; 142: 126-35. (Pubitemid 351783151)
88. Wang RH, Phillips G Jr, Medof ME, Mold C,. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. J Clin Invest 1993; 92: 1326-35. (Pubitemid 23273908)
89. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, Lee DM,. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580-3.
90. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ,. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340-8. (Pubitemid 16074068)
91. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ,. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 2007; 110: 2166-72. (Pubitemid 47443936)
92. del Conde I, Cruz MA, Zhang H, Lõpez JA, Afshar-Kharghan V,. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201: 871-9. (Pubitemid 40524457)
93. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, Figdor CG,. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 2001; 98: 1802-11.
94. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17. (Pubitemid 29084771)
95. Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassà AM, Bonaparte D, Cavalcante MM, Chora A, Ferreira A, Marguti I, Cardoso S, SepÃlveda N, Smith A, Soares MP,. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med 2010; 2: 51ra71.
96. Azarov I, He XJ, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, Kim-Shapiro DB,. Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 2008; 18: 296-302.
97. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT,. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003; 9: 1498-505. (Pubitemid 38004777)